참고문헌 (86)

1. Prince M , Bryce R , Albanese E , Wimo A , Ribeiro W , Ferri CP . 2013 . The global prevalence of dementia: A systematic review and metaanalysis . Alzheimers Dement 9 ( 1 ): 63 – 75 e62 . 

2. Desai AK , Schwartz L , Grossberg GT . 2012 . Behavioral disturbance in dementia . Curr Psychiatry Rep 14 ( 4 ): 298 – 309 . 

3. Hebert LE , Scherr PA , Bienias JL , Bennett DA , Evans DA . 2003 . Alzheimer disease in the US population: Prevalence estimates using the 2000 census . Arch Neurol 60 ( 8 ): 1119 – 1122 . 

   상세보기

4. Hoyer S . 2000 . Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: An update . Exp Gerontol 35 ( 9–10 ): 1363 – 1372 . 

5. Matsuyama SS , Jarvik LF . 1989 . Hypothesis: Microtubules, a key to Alzheimer disease . Proc Natl Acad Sci USA 86 ( 20 ): 8152 – 8156 . 

   상세보기

6. Flaherty CF , Rowan GA , Emerich DF , Walsh TJ . 1989 . Effects of intrahippocampal administration of colchicine on incentive contrast and on radial maze performance . Behav Neurosci 103 ( 2 ): 319 – 328 . 

   상세보기

7. Calabrese V , Butterfield DA , Stella AM . 2003 . Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer's disease . Ital J Biochem 52 ( 4 ): 177 – 181 . 

8. Kontush K , Schekatolina S . 2004 . Vitamin E in neurodegenerative disorders: Alzheimer's disease . Ann N Y Acad Sci 1031 : 249 – 262 . 

   상세보기

9. Qizilbash N , Birks J , Lopez Arrieta J , Lewington S , Szeto S . 2007 . WITHDRAWN: Tacrine for Alzheimer's disease . Cochrane Database Syst Rev ( 3 ): CD000202 . 

10. Chonpathompikunlert P , Wattanathorn J , Muchimapura S . 2010 . Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease . Food Chem Toxicol 48 ( 3 ): 798 – 802 . 

    상세보기

11. Gupta SK , Bansal P , Bhardwaj RK , Velpandian T . 2000 . Comparative anti‐nociceptive, anti‐inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination . Pharmacol Res 41 ( 6 ): 657 – 662 . 

    상세보기

12. D'Hooge R , Pei YQ , Raes A , Lebrun P , van Bogaert PP , de Deyn PP . 1996 . Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists . Arzneimittelforschung 46 ( 6 ): 557 – 560 . 

13. Lai LH , Fu QH , Liu Y , Jiang K , Guo QM , Chen QY , Yan B , Wang QQ , Shen JG . 2012 . Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model . Acta Pharmacol Sin 33 ( 4 ): 523 – 530 . 

14. Lee SA , Hong SS , Han XH , Hwang JS , Oh GJ , Lee KS , Lee MK , Hwang BY , Ro JS . 2005 . Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant‐like activity . Chem Pharm Bull (Tokyo) 53 ( 7 ): 832 – 835 . 

15. Wattanathorn J , Chonpathompikunlert P , Muchimapura S , Priprem A , Tankamnerdthai O . 2008 . Piperine, the potential functional food for mood and cognitive disorders . Food Chem Toxicol 46 ( 9 ): 3106 – 3110 . 

    상세보기

16. Yusuf M , Khan M , Khan RA , Ahmed B . 2013 . Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model . J Drug Target 3 ( 21 ): 300 – 311 . 

17. Aroonsri Priprem PC , Saengrawee Sutthiparinyanont , Jintanaporn Wattanathorn . 2011 . Antidepressant and cognitive activities of intranasal piperine‐encapsulated liposomes . Adv Biosci Biotechnol 2 : 108 – 116 . 

    상세보기

18. Costantino HR , Illum L , Brandt G , Johnson PH , Quay SC . 2007 . Intranasal delivery: Physicochemical and therapeutic aspects . Int J Pharm 337 ( 1–2 ): 1 – 24 . 

19. Nakamura K , Maitani Y , Lowman AM , Takayama K , Peppas NA , Nagai T . 1999 . Uptake and release of budesonide from mucoadhesive, pH‐sensitive copolymers and their application to nasal delivery . J Control Release 61 ( 3 ): 329 – 335 . 

    상세보기

20. Illum L . 2004 . Is nose‐to‐brain transport of drugs in man a reality? J Pharm Pharmacol 56 ( 1 ): 3 – 17 . 

    상세보기

21. Sastre J , Mosges R . 2012 . Local and systemic safety of intranasal corticosteroid . J Investig Allergol Clin Immunol 22 : 1 – 12 . 

22. Mistry A , Stolnik S , Illum L . 2009 . Nanoparticles for direct nose‐to‐brain delivery of drugs . Int J Pharm 379 ( 1 ): 146 – 157 . 

    상세보기

23. Yoshino T , Machida Y , Onishi H , Nagai T . 2003 . Preparation and characterization of chitosan microspheres containing doxifluridine . Drug Dev Ind Pharm 29 ( 4 ): 417 – 427 . 

    상세보기

24. Nagpal K , Singh SK , Mishra DN . 2013 . Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety . Int J Biol Macromol 59 : 72 – 83 . 

    상세보기

25. Pavinatto A , Pavinatto FJ , Barros‐Timmons A , Oliveira ON Jr . 2010 . Electrostatic interactions are not sufficient to account for chitosan bioactivity . ACS Appl Mater Interfaces 2 ( 1 ): 246 – 251 . 

    상세보기

26. Illum L , Farraj NF , Davis SS . 1994 . Chitosan as a novel nasal delivery system for peptide drugs . Pharm Res 11 ( 8 ): 1186 – 1189 . 

    상세보기

27. Kim MS , You HJ , You MK , Kim NS , Shim BS , Kim HM . 2004 . Inhibitory effect of water‐soluble chitosan on TNF‐alpha and IL‐8 secretion from HMC‐1 cells . Immunopharmacol Immunotoxicol 26 ( 3 ): 401 – 409 . 

28. Amidi M , Romeijn SG , Borchard G , Junginger HE , Hennink WE , Jiskoot W . 2006 . Preparation and characterization of protein‐loaded N‐trimethyl chitosan nanoparticles as nasal delivery system . J Control Release 111 ( 1–2 ): 107 – 116 . 

29. Vaka SR , Shivakumar HN , Repka MA , Murthy SN . 2013 . Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration . J Drug Target 21 ( 1 ): 44 – 53 . 

    상세보기

30. Prashant Sahu AB , Chaurasia Anand , Gajbhiye Virendra . 2012 . Higher therapautic benefits of piperine loaded optimized chitosan microspheres for improved hepatoprotective potentials . Res Gate Pharm Sci 1 ( 1 ): 39 – 44 . 

31. Elnaggar YS , El‐Massik MA , Abdallah OY . 2011 . Sildenafil citrate nanoemulsion vs. self‐nanoemulsifying delivery systems: Rational development and transdermal permeation . Int J Nanotechnol 8 ( 8 ): 749 – 763 . 

    상세보기

32. Rajpal V . 2002 . Piper Nigrum . Standardization of botanicals . New Delhi : Eastern Publications , pp. 258 , 267 . 

33. Calvo P , Remunan‐Lopez C , Vila‐Jato JL , Alonso MJ . 1997 . Chitosan and chitosan/ethylene oxide‐propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines . Pharm Res 14 ( 10 ): 1431 – 1436 . 

    상세보기

34. Vila A , Sanchez A , Tobio M , Calvo P , Alonso MJ . 2002 . Design of biodegradable particles for protein delivery . J Control Release 78 ( 1–3 ): 15 – 24 . 

35. Aktas Y , Andrieux K , Alonso MJ , Calvo P , Gursoy RN , Couvreur P , Capan Y . 2005 . Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor . Int J Pharm 298 ( 2 ): 378 – 383 . 

    상세보기

36. Elnaggar YS , El‐Massik MA , Abdallah OY . 2011 . Fabrication, appraisal, and transdermal permeation of sildenafil citrate‐loaded nanostructured lipid carriers versus solid lipid nanoparticles . Int J Nanomed 6 : 3195 – 3205 . 

37. Freag MS , Elnaggar YS , Abdallah OY . 2013 . Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: Optimization and ex vivo permeation . Int J Nanomed 8 : 2385 – 2397 . 

38. Fazil M , Md S , Haque S , Kumar M , Baboota S , Sahni JK , Ali J . 2012 . Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting . Eur J Pharm Sci 47 ( 1 ): 6 – 15 . 

    상세보기

39. D'Hooge R , De Deyn PP . 2001 . Applications of the Morris water maze in the study of learning and memory . Brain Res Brain Res Rev 36 ( 1 ): 60 – 90 . 

40. Ganguly R , Guha D . 2008 . Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera . Indian J Med Res 128 ( 6 ): 744 – 751 . 

    상세보기

41. Veerendra Kumar MH , Gupta YK . 2002 . Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats . Pharmacol Biochem Behav 73 ( 3 ): 565 – 571 . 

    상세보기

42. Terry AV Jr . 2009 . Spatial navigation (water maze) tasks . In Buccafusco JJ , editor. Methods of behavior analysis in neuroscience . 2nd ed . Taylor & Francis Group, LLC Boca Raton, Florida . 

43. Wills ED . 1966 . Mechanisms of lipid peroxide formation in animal tissues . Biochem J 99 ( 3 ): 667 – 676 . 

    상세보기

44. Koracevic D , Koracevic G , Djordjevic V , Andrejevic S , Cosic V . 2001 . Method for the measurement of antioxidant activity in human fluids . J Clin Pathol 54 ( 5 ): 356 – 361 . 

    상세보기

45. Kono Y . 1978 . Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase . Arch Biochem Biophys 186 ( 1 ): 189 – 195 . 

    상세보기

46. Woodruff‐Pak DS , Tobia MJ , Jiao X , Beck KD , Servatius RJ . 2006 . Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil . Neuropsychopharmacology 32 ( 6 ): 1284 – 1294 . 

47. Ellman GL , Courtney KD , Andres V Jr. , Feather‐Stone RM . 1961 . A new and rapid colorimetric determination of acetylcholinesterase activity . Biochem Pharmacol 7 : 88 – 95 . 

    상세보기

48. Casciola‐Rosen L , Nicholson DW , Chong T , Rowan KR , Thornberry NA , Miller DK , Rosen A . 1996 . Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death . J Exp Med 183 ( 5 ): 1957 – 1964 . 

    상세보기

49. Tiwari V , Chopra K . 2011 . Resveratrol prevents alcohol‐induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain . J Neurochem 117 ( 4 ): 678 – 690 . 

    상세보기

50. Lowry OH , Rosebrough NJ , Farr AL , Randall RJ . 1951 . Protein measurement with the Folin phenol reagent . J Biol Chem 193 ( 1 ): 265 – 275 . 

51. Chan YH . 2003 . Biostatistics 102: Quantitative data–parametric & non‐parametric tests . Singapore Med J 44 ( 8 ): 391 – 396 . 

    상세보기

52. Kotz S BN , Read CB , Vidakovic B . 2006 . Encyclopedia of statistical sciences . Hobojen, New Jersey : John Wiley & Sons . 

53. Elnaggar YS , El‐Refaie WM , El‐Massik MA , Abdallah OY . 2014 . Lecithin‐based nanostructured gels for skin delivery: An update on state of art and recent applications . J Control Release 180 : 10 – 24 . 

    상세보기

54. Elsheikh MA , Elnaggar YS , Gohar EY , Abdallah OY . 2012 . Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: Optimization and in vivo appraisal . Int J Nanomed 7 : 3787 – 3802 . 

55. Freag MS , Elnaggar YS , Abdallah OY . 2013 . Development of novel polymer‐stabilized diosmin nanosuspensions: In vitro appraisal and ex vivo permeation . Int J Pharm 454 ( 1 ): 462 – 471 . 

    상세보기

56. Elsheikh MA , Elnaggar YS , Abdallah OY . 2014 . Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers . J Control Release 194 : 92 – 102 . 

    상세보기

57. El‐Refaie WM , Elnaggar YS , El‐Massik MA , Abdallah OY . 2015 . Novel curcumin‐loaded gel‐core hyaluosomes with promising burn‐wound healing potential: Development, in‐vitro appraisal and in‐vivo studies . Int J Pharm 486 ( 1–2 ): 88 – 98 . 

58. Elnaggar YS . 2015 . Multifaceted implementations of bile salts in pharmacy: An emphasis on nanomedicine. Int . J. Nanomed 10 : 1 – 17 . 

59. El‐Refaie WM , Elnaggar YS , El‐Massik MA , Abdallah OY . 2015 . Novel self‐assembled, gel‐core hyaluosomes for non‐invasive management of osteoarthritis: In‐vitro optimization, ex‐vivo and in‐vivo permeation . Pharm Res . 32 ( 4 ). 

60. Calvo P , Remu˜nán‐López C , Vila‐Jato JL , Alonso MJ . 1997 . Novel hydrophilic chitosan–polyethylene oxide nanoparticles as protein carriers . J Appl Poly Sci 63 : 125 – 132 . 

61. Sharma TASaCP . 2011 . Chitosan and its derivatives for drug delivery perspective . Adv Polym Sci ( 243 ): 30 . 

62. Xu Y , Du Y . 2003 . Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles . Int J Pharm 250 ( 1 ): 215 – 226 . 

    상세보기

63. Zhang X , Sun M , Zheng A , Cao D , Bi Y , Sun J . 2012 . Preparation and characterization of insulin‐loaded bioadhesive PLGA nanoparticles for oral administration . Eur J Pharm Sci 45 ( 5 ): 632 – 638 . 

    상세보기

64. Kumar A , Seghal N , Naidu PS , Padi SS , Goyal R . 2007 . Colchicines‐induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type . Pharmacol Rep 59 ( 3 ): 274 – 283 . 

    상세보기

65. Kumar A , Dogra S , Prakash A . 2009 . Neuroprotective effects of centella asiatica against intracerebroventricular colchicine‐induced cognitive impairment and oxidative stress . Int J Alzheimers Dis 2009 : 972178 . 

66. O Choi A , Maysinger D . 2013 . Intranasal fluorescent nanocrystals for longitudinal in vivo evaluation of cerebral microlesions . Pharm Nanotechnol 1 ( 2 ): 93 – 104 . 

67. Riedel G , Platt B , Micheau J . 2003 . Glutamate receptor function in learning and memory . Behav Brain Res 140 ( 1–2 ): 1 – 47 . 

68. Halliwell B , Gutteridge JM , Cross CE . 1992 . Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 119 ( 6 ): 598 – 620 . 

    상세보기

69. Massaad CA , Klann E . 2011 . Reactive oxygen species in the regulation of synaptic plasticity and memory . Antioxid Redox Signal 14 ( 10 ): 2013 – 2054 . 

    상세보기

70. Husain K , Somani SM . 1997 . Interaction of exercise training and chronic ethanol ingestion on hepatic and plasma antioxidant system in rat . J Appl Toxicol 17 ( 3 ): 189 – 194 . 

    상세보기

71. Kusano C , Ferrari B . 2008 . Total antioxidant capacity: A biomarker in biomedical and nutritional studies . J Cell Mol Biol 7 ( 1 ): 16 . 

72. Prado VF , Martins‐Silva C , de Castro BM , Lima RF , Barros DM , Amaral E , Ramsey AJ , Sotnikova TD , Ramirez MR , Kim HG , Rossato JI , Koenen J , Quan H , Cota VR , Moraes MF , Gomez MV , Guatimosim C , Wetsel WC , Kushmerick C , Pereira GS , Gainetdinov RR , Izquierdo I , Caron MG , Prado MA . 2006 . Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition . Neuron 51 ( 5 ): 601 – 612 . 

    상세보기

73. Dai J , Buijs RM , Kamphorst W , Swaab DF . 2002 . Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes . Brain Res 948 ( 1–2 ): 138 – 144 . 

74. Roberson MR , Harrell LE . 1997 . Cholinergic activity and amyloid precursor protein metabolism . Brain Res Brain Res Rev 25 ( 1 ): 50 – 69 . 

75. Smith A , Perelman M , Hinchcliffe M . 2014 . Chitosan: A promising safe and immune‐enhancing adjuvant for intranasal vaccines . Hum Vaccin Immunother 10 ( 3 ): 797 – 807 . 

    상세보기

76. Hawkins BT , Davis TP . 2005 . The blood‐brain barrier/neurovascular unit in health and disease . Pharmacol Rev 57 ( 2 ): 173 – 185 . 

    상세보기

77. Liu Z , Gastard M , Verina T , Bora S , Mouton PR , Koliatsos VE . 2001 . Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus . J Comp Neurol 441 ( 1 ): 1 – 8 . 

    상세보기

78. Kumar A , Seghal N , Padi SV , Naidu PS . 2006 . Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine‐induced dysfunction and oxidative stress in rats . Euro J pharmacol 551 ( 1 ): 58 – 66 . 

79. Md S , Khan RA , Mustafa G , Chuttani K , Baboota S , Sahni JK , Ali J . 2013 . Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, pharmacokinetic and scintigraphy study in mice model . Eur J Pharm Sci 48 ( 3 ): 393 – 405 . 

    상세보기

80. Wang X , Chi N , Tang X . 2008 . Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting . Euro J Pharm Biopharm 70 ( 3 ): 735 – 740 . 

81. Al‐Ghananeem AM , Saeed H , Florence R , Yokel RA , Malkawi AH . 2009 . Intranasal drug delivery of didanosine‐loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses . J Drug Target 18 ( 5 ): 381 – 388 . 

82. Friedman AJ , Phan J , Schairer DO , Champer J , Qin M , Pirouz A , Blecher‐Paz K , Oren A , Liu PT , Modlin RL , Kim J . 2013 . Antimicrobial and anti‐inflammatory activity of chitosan‐alginate nanoparticles: A targeted therapy for cutaneous pathogens . J Invest Dermatol 133 ( 5 ): 1231 – 1239 . 

    상세보기

83. Oliveira MI , Santos SG , Oliveira MJ , Torres AL , Barbosa MA . 2012 . Chitosan drives anti‐inflammatory macrophage polarisation and pro‐inflammatory dendritic cell stimulation . Eur Cell Mater 24 : 136 – 152 ; discussion 152–133. 

84. Yang E‐J , Kim J‐G , Kim J‐Y , Kim S , Lee N , Hyun C‐G . 2010 . Anti‐inflammatory effect of chitosan oligosaccharides in RAW 264.7 cells . Centl Euro J Biol 5 ( 1 ): 95 – 102 . 

85. Rinwa P , Kumar A , Garg S . 2013 . Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression . PLoS One 8 ( 4 ): e61052 . 

86. Shrivastava P , Vaibhav K , Tabassum R , Khan A , Ishrat T , Khan MM , Ahmad A , Islam F , Safhi MM , Islam F . 2013 . Anti‐apoptotic and anti‐inflammatory effect of Piperine on 6‐OHDA induced Parkinson's rat model . J Nutr Biochem 24 ( 4 ): 680 – 687 . 

    상세보기